Literature DB >> 8456819

Fragilitas ossium (fro/fro) in the mouse: a model for a recessively inherited type of osteogenesis imperfecta.

D O Sillence1, H E Ritchie, T Dibbayawan, D Eteson, K Brown.   

Abstract

The fragilitas ossium (fro/fro) mutation in the mouse has been demonstrated to have clinical, radiographic and morphologic manifestations similar to those which arise in autosomal recessive forms of osteogenesis imperfecta (OI) occurring in humans. Approximately 90% of mutant offspring in the mouse were perinatally lethal with clinical and roentgenographic findings similar to those of OI type II subgroup A in humans. The 10% of mutant mice surviving follow a course very similar to severe progressively deforming OI type III. In surviving mice, there is progressive fore-limb and hind-limb bowing in the absence of a high fracture frequency.

Entities:  

Mesh:

Year:  1993        PMID: 8456819     DOI: 10.1002/ajmg.1320450227

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  Sphingomyelin degradation is a key factor in dentin and bone mineralization: lessons from the fro/fro mouse. The chemistry and histochemistry of dentin lipids.

Authors:  M Goldberg; S Opsahl; I Aubin; D Septier; C Chaussain-Miller; A Boskey; J-L Guenet
Journal:  J Dent Res       Date:  2008-01       Impact factor: 6.116

2.  RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta.

Authors:  Renee Bargman; Alice Huang; Adele L Boskey; Cathleen Raggio; Nancy Pleshko
Journal:  Connect Tissue Res       Date:  2010-04       Impact factor: 3.417

3.  Comparison of bone tissue properties in mouse models with collagenous and non-collagenous genetic mutations using FTIRI.

Authors:  Rhima M Coleman; Laura Aguilera; Layla Quinones; Lyudamila Lukashova; Christophe Poirier; Adele Boskey
Journal:  Bone       Date:  2012-08-15       Impact factor: 4.398

4.  Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression.

Authors:  Wilhelm Stoffel; Britta Jenke; Barbara Holz; Erika Binczek; Robert Heinz Günter; Jutta Knifka; Jürgen Koebke; Anja Niehoff
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

5.  Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema.

Authors:  Christophe Poirier; Evgeny V Berdyshev; Christiana Dimitropoulou; Natalia V Bogatcheva; Paul W Biddinger; Alexander D Verin
Journal:  Mamm Genome       Date:  2012-09-04       Impact factor: 2.957

Review 6.  Animal models of osteogenesis imperfecta and related syndromes.

Authors:  Agnès S Kamoun-Goldrat; Martine F Le Merrer
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.